Project Call

Eva Garland Consulting, LLC COVID-19 Funding Opportunities

Funding Agencies (Click to jump to agency)

Biomedical Advanced Research and Development Authority (BARDA)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Department of Defense (DOD)
US Department of Agriculture (USDA)
Other US Funding Agencies
International Opportunities

Biomedical Advanced Research and Development Authority (BARDA)

BARDA has updated its Broad Agency Announcements (BAAs) to focus exclusively on addressing the COVID-19 threat.  BARDA’s annual budget of $512 Million has been supplemented by an additional $3.5 billion through the recently passed Coronavirus Aid, Relief, and Economic Security (CARES) Act.  The additional funding is allocated for necessary expenses of manufacturing, production, and purchase of various supplies and services.


View Solicitation

Topic: Products to diagnose, prevent or treat novel coronavirus infections
Due Date: Rolling, through 10/31/2020
Budget: Unlimited

Division of Research, Innovation & Ventures (DRIVe) BAA

View Solicitation

Topics: Diagnostic assays, screening and model development, vaccines, advanced manufacturing.

Due Date: Abstract submissions due by 5PM ET on 6/30/2020.
Budget: $750,000


While CoronaWatch is not a direct funding mechanism, the U.S. government seeks information from stakeholders on available medical countermeasures in development for COVID-19. A CoronaWatch meeting is held by interactive webinar, in which the presenting team displays slides and engages with government personnel.  A CoronaWatch meeting is encouraged prior to applying for BARDA funding, so that organizations can better align their product development with government priorities.

Request CoronaWatch Meeting

National Institutes of Health (NIH)

Notices of Special Interest (NOSI)

Multiple NIH Institutes have issued a Notice of Special Interest (NOSI) to provide funding for research topics related to COVID-19.  For most of these opportunities, the applicant must have an active award through the Institute with sufficient time remaining to complete all studies proposed.

National Institute on Aging (NIA), National Institute of Mental Health (NIMH)

NOSI Regarding Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
  • PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements for NIH grantees applying to expand the scope of their active grant.
  • PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant.

Topics:  NIA – Mission critical areas as they relate to the COVID-19 pandemic. NIMH – Applications addressing care for new or worsening mental health needs and/or suicide risk in midlife and older age adults will be seen as a high priority.

Due Date: Rolling until 5/1/2021
Budget: Limited to no more than that amount of the current parent award.

National Heart, Lung, Blood Institute (NHLBI)

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

Topic: COVID-19 related research including host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

Due Date: Rolling, through 10/5/2020
Budget: Not specified

National Institute of Allergy and Infectious Diseases (NIAID)

NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

Topics: Viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19.

Due Date: Rolling until 3/25/2021
Budget: Not Specified

National Institute of General Medical Sciences (NIGMS)

NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2

Topics: Predictive models for the spread of SARS-CoV-2 and other related infectious agents (all relevant grants). Repurposing or modification of diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection; rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR grants only).

Due Date: Rolling, through 2/6/2021
Budget: Not Specified

National Center for Advancing Translational Sciences (NCATS)

NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need

Topics: Use of informatics solutions to diagnose cases and the use of CTSA-supported core resources to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines.

PA-18-591 – Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Due Dates: 5/4/2020, 11/2/2020
Budget: Application budgets are limited to no more than the amount of the current parent award and must reflect the actual needs of the proposed project.

PAR-19-099 – Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)

Due Dates: 7/10/2020, 11/9/2020, 3/8/2021, 7/9/2021
Budget: $400,000 – $750,000

PAR-19-100 – Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

Due Dates: 7/10/2020, 11/9/2020, 3/8/2021, 7/9/2021
Budget: $275,000 (direct costs)

PAR-19-337 – Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional).

Due date: 9/25/2020
Budget: $750,000/year in direct costs excluding consortium/contractual F&A costs.

Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)

Topics: Using innovative processes to identify the therapeutic/indication pair for use to treat COVID-19.

PAR-17-465 – Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)

Due Dates: 6/26/2020
Budget: $200,000 direct costs/year for UG3 proposals and $100,000 direct costs for UH3 proposals.

PA-18-462 – Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trial Not Allowed)

Due Dates: 6/16/2020, 10/16/2020
Budget: $225,000 (direct costs)

PAR-18-332 – Clinic Testing Therapeutic/Indications Pairing Strategies (U01 Clinical Trial Required)

Due Dates: 6/5/2020, 10/5/2020
Budget: $3,000,000 in direct costs per year.

National Institute of Environmental Health Sciences (NIEHS)

NOSI: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)

Topics: Support worker-based training to prevent and reduce exposure of hospital employees, emergency first responders, and other workers who are at risk of exposure to Coronavirus through their work duties.

PA-20-135 – Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)

Due Date: 4/24/2020
 No Limit

National Institute of Drug Abuse (NIDA)

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

Topic: NIDA is interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.

Due Date: Rolling, through 3/31/2021
Budget: Maximum of $100,000 direct costs per year for 2 years.  Higher budgets may be considered with justification.

National Human Genome Research Institute (NHGRI)

Topics: Genomic studies utilizing generalized approaches that take advantage of human research or model systems to study the consequences of SARS-CoV-2 infection. Supported research is expected to guide and inform future efforts to diagnose, prevent, mitigate, or treat this viral infection.

View Solicitation

Related Announcements:

  • PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) is intended to provide funds for NIH grantees applying to expand the scope of their active grant.
  • PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) is intended to provide funds for NIH grantees where the work proposed in the supplement is fully within the scope of the ongoing grant.

Due Date: 5/15/2020 at 5PM Local Time
Budget: $250,000/year in direct costs

National Science Foundation (NSF)

Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19

NSF is seeking Phase I SBIR/STTR proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis.

View Letter

Topics: Artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations.

Due Date: Rolling, Project Pitch submission required. NSF is committed to expediting review, with the hope of granting awards within 6 weeks of proposal receipt.
Budget: $256,000

Dear Colleague Letter on the Coronavirus

View Letter

The NSF encourages investigators to use existing NSF funding mechanisms to submit proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.

For proposals of up to $200K, NSF encourages using the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency.

Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)

View Letter

The Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.

Department of Defense (DOD)

Congressionally Directed Medical Research Programs (CDMRP)

Peer Reviewed Medical Research Program (PRMRP)

Three of the FY20 PRMRP mechanisms are focused on Emerging Viral Diseases and Respiratory Health.

PRMRP Home Page


Due Date: Letter of Intent – Starting 5/28/2020, Full Application – Starting 6/12/2020
Budget: Varies by Program

DoD Newton Award for Transformative Ideas during the COVID-19 Pandemic

View Solicitation

Topics: This award will be presented to a single investigator or team of up to two investigators that develops a “transformative idea” to resolve challenges, advance frontiers, and set new paradigms in areas of immense potential benefit to DoD and the nation at large.

Due Date: 5/15/2020
Award: $10,000 – $100,000

Air Force

SBIR Commercial Solutions Opening (CSO) AF Ventures Direct-to-Phase II

This CSO seeks innovative, commercial technologies proposed to create new AF solutions or potential new capabilities fulfilling requirements, closing capability gaps, or providing potential technological advancements.

View Solicitation

Topics: Focus areas of interest include, but are not limited to the following:

  • Decision Support: social media analytics, adware proximity algorithm, mobile application self-reporting
  • Personnel Needs: Tele-Health, Tele-Counseling
  • Readiness: Impact assessment tools, training scheduling optimization tools
  • Logistics
  • Medical: Air and surface cleansing, COVID-19 testing and management, COVID-19 medical supply chain

Due Date: 4/30/2020 by 12PM EDT
Budget: $1,000,000 (Can exceed amount with matching Government funds)

Medical Technology Enterprise Consortium (MTEC)

Development of Treatments for COVID-19

MTEC is an enterprise partnership in collaboration with industry and academia to facilitate research and development activities, in cooperation with the U.S. Army Medical Research and Development Command (USAMRDC) and other DoD agencies in the biomedical sciences MTEC membership is not required for proposal submission, but it is required for an award.

MTEC is expected to release several funding opportunities soon, and pre-Announcements are posted here:

View MTEC Upcoming Solicitations

US Department of Agriculture (USDA)

National Institute of Food and Agriculture (NIFA)

In response to the current need for more COVID-19 information, certain NIFA programs will allow submission of COVID-19 relevant projects outside of their normal deadlines.  Frequently Asked Questions regarding COVID-19 submissions can be found below.

View FAQs

Agriculture and Food Research Initiative (AFRI)

View Solicitation

Topics: Focus areas of interest include, but are not limited to the following:

  • Animal Nutrition, Growth and Lactation (A1231)
  • Critical Agricultural Research and Extension (CARE) (A1701)
  • Diseases of Agricultural Animals (A1221)
  • Food Safety and Defense (A1332)
  • Foundational Knowledge of Plant Products (A1103)
  • Economics, Markets, and Trade (A1641)

Due Date: Varies by Program
Budget: $1,000,000

Small Business Innovation Research (SBIR)

View Solicitation

Topics: Projects must fit the topics covered by the specific program that you are applying under.  All projects must include “COVID-19 Rapid Response” in the title.

Due Date: 5/21/2020
Budget: $100,000

Other US Funding Agencies

National Institute of Standards and Technology (NIST)

NIST Manufacturing USA National Emergency Assistance Program

NIST invites applications from the 2,000 current Manufacturing USA institutes, including small manufacturers, two-thirds of Fortune 50 U.S. manufacturers, and nearly every top ranked research and engineering university in the United States.

View Solicitation

Topic: Projects should focus on responding to the COVID-19 pandemic. Projects may include medical countermeasures; non-medical countermeasures; leveraging institute capabilities to strengthen state and community resilience; grants to companies and technical support to accelerate productions of critical materials, equipment, and supplies; creation of additional production facilities; technology roadmapping for pandemic response and recovery; reshoring the manufacture of critical conventional drugs and ensuring supply chain for critical materials related to pandemic response; or workforce development and training for a skilled advanced manufacturing workforce.

Due Date: Rolling
Budget: $250,000 – $10 million

Coalition for Epidemic Preparedness Innovation (CEPI)

Multi-purpose platform technologies for rapid response against emerging infectious diseases

View Solicitations

Topic: Vaccine and adaptive epidemic response platform development

Due Date: Expressions of Interest (EOIs) will be accepted on a rolling basis until 10/14/2020.
Budget: Not specified

Medical CBRN Defense Consortium (MCDC)

Request for Information (RFI) – CoV Pandemic Response

View RFI

MCDC is requesting proposals regarding rapidly deployable (1-6 months) products and technologies to combat the current pandemic.  Longer-term solutions are not requested in this RFI.

Topic: COVID-19-related Diagnostics/Monitoring, Surveillance, Information Systems for Point of Care, Therapeutics, Prophylactics, Clinical Trials

Due Date: 5/31/2020
Budget: Not Specified

California Institute for Regenerative Medicine

Special Call for COVID-19 Projects

View Solicitation

Topics: Discovery, preclinical, and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need.

Due Date: Bi-monthly, ongoing
Budget: $150,000 – $750,000

CoVent-19 Challenge

The CoVent-19 Challenge is an open innovation 8-week ventilator design and prototyping for engineers, innovators, designers, and makers. The two round challenge aims to create ventilator CAD assemblies by May 1, 2020 (Round 1: General Admission) and functional prototypes demonstrating acceptable performance by June 1, 2020 (Round 2: Invitation Only).

View Challenge

Due Date: 5/1/2020
Budget: The program states that resources will be provided for invited teams to finalize their design and creating functional prototypes.

Amazon Web Services (AWS)

AWS Diagnostic Development Initiative (DDI)

View Solicitation

Topics: Using AWS to support research-oriented workloads for the development of point-of-care diagnostic (testing that can be done at home or at a clinic with same-day results) and other diagnostic techniques.  Initial emphasis will be on the COVID-19 coronavirus disease, but other infectious disease diagnostic projects will be considered.

Due Date: Submissions accepted until 6/30/2020. Funding decisions will be made within 45 days of submission.
Budget: Awards will consist of promotional credits to be put toward AWS resource usage.

Fast Grants

Fast Grants are available exclusively to PIs at academic institutions already working on COVID-19 related projects that could help with the pandemic within the next six months.

View Solicitation

Topics: All COVID-19 related science

Due Date: Rolling, award decisions made in 48 hours.
Budget: $10,000 – $500,000


Antler is a global early-stage VC firm that builds and invests in groundbreaking technology companies.  Successful applicants will receive an investment of US$100,000 and have the opportunity to join an Antler program at a location closest to them, with most modules being remote.

View Solicitation

Topics: Mitigation, Medical Equipment, Remote Health, Digital Tools related to COVID-19

Due Date: 4/15/2020
Budget: $100,000 (investment)

International Opportunities

Deutsche Forschungsgemeinschaft (German Research Foundation)

View Solicitation (English)

Topics: Prevention, early detection, containment and investigation of the causes, impacts and management of epidemics and pandemics

Due Date: Letter of Intent – 7/1/2020; Full Proposal – 9/1/2020
Budget: Not Specified

Nordic Trial Alliance

Representatives of Nordic research performing organisations, public sector, patient organisations or other relevant organisations are eligible to apply.

View Solicitation

Topics: Strengthening Nordic collaboration and contributing to global knowledge of COVID-19.

Due Date: 4/15/2020, with award decisions made by 4/30/2020
Budget: 500,000 NOK

UK Research and Innovation (UKRI)

Proposals will be accepted from anyone who is normally eligible to apply for UKRI funding. You will need to show that you can start work within 4 weeks of the funding being confirmed.

View Solicitation

Topics: Short-term projects (12-18 months) addressing and mitigating the health, social, economic, cultural and environmental impacts of the COVID-19 outbreak.

Due Date: Ongoing
Budget: 80% of the full economic cost

Islamic Development Bank (IsDB)

Transform Fund Call for Innovation 2020

The Transform Fund Call for Innovation 2020 will focus entirely on supporting IsDB Member Countries’ long-term preparedness and response to the COVID-19 pandemic.  IsBD invests through Grants, Equity Participations and Quasi Equity Participation.

View Solicitation

Topics: Tackling COVID-19 in relation to six UN Sustainable Development Goals.

Due Date: 6/1/2020
Budget: $50,000 – $1,000,000

British Society for Antimicrobial Chemotherapy (BSAC)

COVID-19 Funding Call

BSAC is launching a COVID-19 funding call to support researchers in better understanding and addressing the COVID-19 outbreak.

View Solicitation

Topics: New projects or extension of existing research projects to improve understanding and addressing the COVID-19 outbreak.

Due Date: Expressions of interest due 4/17/2020
Budget: Up to £25,000

Novo Nordisk Foundation (Denmark)

View Application Information (Danish)

Eligibility: Public or private institutions in Denmark


  • Scientific projects that test new treatments, techniques and technologies or preventive initiatives that can rapidly be used to manage the challenges the health system faces in the current situation;
  • Information and outreach initiatives that can improve the communication to the public and their understanding and knowledge about how the health aspects of the crisis are being managed; and
  • Social initiatives designed to meet the special health needs of vulnerable groups affected by the crisis.

Budget: Up to DDK 5 million
Due Date: Applications accepted through 6/18/2020
Note: Application turnaround time is ~48 hours

Israel Innovation Authority

Call for Proposals for R&D Plans of Industrial Products for the Prevention and Treatment of the COVID-19 (Coronavirus)

View Solicitation

Topic: R&D plans submission may include the development of products, raw materials, innovative technologies and manufacturing processes, practical demonstrations, development of prototypes in the final stages of R&D or developing a scaling process for the transition from experimental production to mass-production.

Due Date: Multiple due dates through 5/18/2020
Budget: 30% to 70% of R&D costs will be supported.

For more information:

Leave a Comment